
Sign up to save your podcasts
Or


Early reports revealed AstraZeneca's vaccine generates antibodies and T-Cells in the Oxford University phase 1 trial. The official data and results are set to be published today and could have a huge impact on the stock market.
By Dumb Money4.7
110110 ratings
Early reports revealed AstraZeneca's vaccine generates antibodies and T-Cells in the Oxford University phase 1 trial. The official data and results are set to be published today and could have a huge impact on the stock market.

3,377 Listeners

1,991 Listeners

395 Listeners

1,833 Listeners

2,121 Listeners

360 Listeners

10,017 Listeners

778 Listeners

440 Listeners

134 Listeners

277 Listeners

558 Listeners

472 Listeners

28 Listeners

77 Listeners